ITGAE and neoplasm: In addition, vaccination with Stat3∆/∆ CD103+ cDC1s led to decreased mean tumor mass in vaccinated but not non-vaccinated tumors 10 days after delivery of the therapy, compared to PBS-treated controls (Figure 2D).